163 related articles for article (PubMed ID: 10885900)
1. Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine.
Gross M; Hiesse C; Kriaa F; Goldwasser F
Anticancer Drugs; 1999 Jul; 10(6):533-6. PubMed ID: 10885900
[TBL] [Abstract][Full Text] [Related]
2. Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin.
Lewin SN; Mutch DG; Whitcomb BP; Liapis H; Herzog TJ
Gynecol Oncol; 2005 Apr; 97(1):228-33. PubMed ID: 15790464
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma.
Kalra N; Kad R; Osama S
Int J Clin Oncol; 2007 Oct; 12(5):385-7. PubMed ID: 17929123
[TBL] [Abstract][Full Text] [Related]
4. Haemolytic uraemic syndrome associated with gemcitabine.
Moya-Horno I; Querol Niñerola R; Bonfill Abella T; Dalmau Pórtulas E; Gallardo-Díaz E; Saigí Grau E; Pericay Pijaume C
Clin Transl Oncol; 2010 May; 12(5):381-3. PubMed ID: 20466623
[TBL] [Abstract][Full Text] [Related]
5. Is thrombotic microangiopathy associated with antitumoral activity?
Chopin N; Alexandre J; Chapron C; Moachon L; Goldwasser F
Gynecol Oncol; 2006 Jun; 101(3):549-50. PubMed ID: 16527338
[No Abstract] [Full Text] [Related]
6. Hemolytic-uremic syndrome caused by gemcitabine.
Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
[No Abstract] [Full Text] [Related]
7. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
8. Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.
Wang F; Du X; Li X; Liu N; Yu H; Sheng X
Medicine (Baltimore); 2016 Dec; 95(51):e5696. PubMed ID: 28002342
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report.
Citarrella P; Gebbia V; Teresi M; Miceli S; Sciortino G; Vaglica M; Pizzardi N; Palmeri S
Anticancer Res; 2002; 22(2B):1183-5. PubMed ID: 12168922
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-associated hemolytic-uremic syndrome.
Walter RB; Joerger M; Pestalozzi BC
Am J Kidney Dis; 2002 Oct; 40(4):E16. PubMed ID: 12324937
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.
Müller S; Schütt P; Bojko P; Nowrousian MR; Hense J; Seeber S; Moritz T
Ann Hematol; 2005 Feb; 84(2):110-4. PubMed ID: 15340761
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?].
Graas MP; Houbiers G; Demolin G; Stultiens A; Focan C
Rev Med Liege; 2012 Dec; 67(12):644-8. PubMed ID: 23342875
[TBL] [Abstract][Full Text] [Related]
14. Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).
Assi C; Lepage C; Jouve JL; Sgro C; Bedenne L
Gastroenterol Clin Biol; 2010 Nov; 34(11):640-2. PubMed ID: 21051168
[No Abstract] [Full Text] [Related]
15. Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.
Harper P
Semin Oncol; 2003 Aug; 30(4 Suppl 10):2-12. PubMed ID: 12917815
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.
Nieto-Ríos JF; Zuluaga-Quintero M; Higuita LM; Rincón CI; Galvez-Cárdenas KM; Ocampo-Kohn C; Aristizabal-Alzate A; Florez-Vargas AA; Zuluaga-Valencia GA
J Bras Nefrol; 2016 Jun; 38(2):255-9. PubMed ID: 27438981
[TBL] [Abstract][Full Text] [Related]
17. [Experience with gemcitabine-carboplatin chemotherapy in relapsed ovarian cancer].
Lehoczky O; Pulay T
Orv Hetil; 2006 Jul; 147(30):1405-8. PubMed ID: 16977778
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD
Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Gray JR; Morrissey LH; Kalman LA; Hon JK; Greco FA
J Clin Oncol; 2002 Jul; 20(13):2937-42. PubMed ID: 12089222
[TBL] [Abstract][Full Text] [Related]
20. [Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature].
Desramé J; Duvic C; Bredin C; Béchade D; Artru P; Brézault C; Defuentes G; Poirier JM; Dourthe LM; Coutant G; Chaussade S; de Gramont A; Algayres JP
Rev Med Interne; 2005 Mar; 26(3):179-88. PubMed ID: 15777580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
